Anti-CX3CR1 Monoclonal Antibody, Clone 9F21.E0 (DCABH-7911) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use

Total Page：16

File Type：pdf, Size：1020Kb

Anti-CX3CR1 monoclonal antibody, clone 9F21.E0 (DCABH-7911) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Mouse monoclonal to CX3CR1 Antigen Description Receptor for the CX3C chemokine fractalkine and mediates both its adhesive and migratory functions. Acts as coreceptor with CD4 for HIV-1 virus envelope protein (in vitro). Isoform 2 and isoform 3 seem to be more potent HIV-1 coreceptors than isoform 1. Immunogen Synthetic peptide corresponding to Human CX3CR1 aa 207-222 conjugated to Keyhole Limpet Haemocyanin (KLH).Sequence: MSYCYFRIIQTLFSCK Database link: P49238 Isotype IgG1 Source/Host Mouse Species Reactivity Human Clone 9F21.E0 Purity Protein G purified Conjugate Unconjugated Applications IHC-P, WB Positive Control Human brain tissue; Human spleen lysate. Format Liquid Size 50 μl Buffer Constituent: 100% PBS Preservative None Storage Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. Ship Shipped at 4°C. GENE INFORMATION 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Gene Name CX3CR1 chemokine (C-X3-C motif) receptor 1 [ Homo sapiens ] Official Symbol CX3CR1 Synonyms CX3CR1; chemokine (C-X3-C motif) receptor 1; chemokine (C X3 C) receptor 1 , CMKBRL1, GPR13; CX3C chemokine receptor 1; CCRL1; CMKDR1; V28; CMK-BRL1; CMK-BRL-1; C-X3-C CKR-1; fractalkine receptor; G protein-coupled receptor 13; G-protein coupled receptor Entrez Gene ID 1524 Protein Refseq NP_001164642 UniProt ID P49238 Chromosome Location 3p21.3 Pathway Chemokine receptors bind chemokines, organism-specific biosystem; Chemokine signaling pathway, organism-specific biosystem; Chemokine signaling pathway, conserved biosystem; Class A/1 (Rhodopsin-like receptors), organism-specific biosystem; Cytokine-cytokine receptor interaction, organism-specific biosystem; Cytokine-cytokine receptor interaction, conserved biosystem; GPCR ligand binding, organism-specific biosystem. Function C-X3-C chemokine receptor activity; G-protein coupled receptor activity; chemokine receptor activity; protein binding; receptor activity; signal transducer activity; 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 2 © Creative Diagnostics All Rights Reserved.

Copy Link

Recommended publications

Atypical Chemokine Receptor 4 Shapes Activated B Cell Fate
Brief Definitive Report Atypical chemokine receptor 4 shapes activated B cell fate Ervin E. Kara,1 Cameron R. Bastow,1 Duncan R. McKenzie,1 Carly E. Gregor,1 Kevin A. Fenix,1 Rachelle Babb,1 Todd S. Norton,1 Dimitra Zotos,3 Lauren B. Rodda,4 Jana R. Hermes,6 Katherine Bourne,6 Derek S. Gilchrist,7 Robert J. Nibbs,7 Mohammed Alsharifi,1 Carola G. Vinuesa,8 David M. Tarlinton,3,9 Robert Brink,6,10 Geoffrey R. Hill,11 Jason G. Cyster,4,5 Iain Comerford,1 and Shaun R. McColl1,2 1Department of Molecular and Cellular Biology, School of Biological Sciences and 2Centre for Molecular Pathology, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia 3Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia 4Department of Microbiology and Immunology and 5Howard Hughes Medical Institute, Department of Microbiology and Immunology, University of California, Downloaded from http://rupress.org/jem/article-pdf/215/3/801/1168927/jem_20171067.pdf by guest on 28 September 2021 San Francisco, San Francisco, CA 6Immunology Division, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia 7Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, UK 8Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia 9Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia 10St Vincent’s Clinical School, University of New South Wales, Darlinghurst, New South Wales, Australia 11Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia Activated B cells can initially differentiate into three functionally distinct fates—early plasmablasts (PBs), germinal center (GC) B cells, or early memory B cells—by mechanisms that remain poorly understood.
[Show full text]
G Protein-Coupled Receptors As Therapeutic Targets for Multiple Sclerosis
npg GPCRs as therapeutic targets for MS Cell Research (2012) 22:1108-1128. 1108 © 2012 IBCB, SIBS, CAS All rights reserved 1001-0602/12 $ 32.00 npg REVIEW www.nature.com/cr G protein-coupled receptors as therapeutic targets for multiple sclerosis Changsheng Du1, Xin Xie1, 2 1Laboratory of Receptor-Based BioMedicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sci- ences and Technology, Tongji University, Shanghai 200092, China; 2State Key Laboratory of Drug Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Pudong New District, Shanghai 201203, China G protein-coupled receptors (GPCRs) mediate most of our physiological responses to hormones, neurotransmit- ters and environmental stimulants. They are considered as the most successful therapeutic targets for a broad spec- trum of diseases. Multiple sclerosis (MS) is an inflammatory disease that is characterized by immune-mediated de- myelination and degeneration of the central nervous system (CNS). It is the leading cause of non-traumatic disability in young adults. Great progress has been made over the past few decades in understanding the pathogenesis of MS. Numerous data from animal and clinical studies indicate that many GPCRs are critically involved in various aspects of MS pathogenesis, including antigen presentation, cytokine production, T-cell differentiation, T-cell proliferation, T-cell invasion, etc. In this review, we summarize the recent findings regarding the expression or functional changes of GPCRs in MS patients or animal models, and the influences of GPCRs on disease severity upon genetic or phar- macological manipulations.
[Show full text]
Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel
Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses This information is current as Endothelial Cell Regulators of September 26, 2021. Carolyn A. Thomson, Serge A. van de Pavert, Michelle Stakenborg, Evelien Labeeuw, Gianluca Matteoli, Allan McI Mowat and Robert J. B. Nibbs J Immunol published online 14 May 2018 Downloaded from http://www.jimmunol.org/content/early/2018/05/11/jimmun ol.1700967 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2018/05/11/jimmunol.170096 Material 7.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2018 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published May 14, 2018, doi:10.4049/jimmunol.1700967 The Journal of Immunology Expression of the Atypical Chemokine Receptor ACKR4 Identiﬁes a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators Carolyn A. Thomson,*,1 Serge A.
[Show full text]
The Chemokine System in Innate Immunity
Downloaded from http://cshperspectives.cshlp.org/ on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press The Chemokine System in Innate Immunity Caroline L. Sokol and Andrew D. Luster Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 Correspondence: [email protected] Chemokines are chemotactic cytokines that control the migration and positioning of immune cells in tissues and are critical for the function of the innate immune system. Chemokines control the release of innate immune cells from the bone marrow during homeostasis as well as in response to infection and inflammation. Theyalso recruit innate immune effectors out of the circulation and into the tissue where, in collaboration with other chemoattractants, they guide these cells to the very sites of tissue injury. Chemokine function is also critical for the positioning of innate immune sentinels in peripheral tissue and then, following innate immune activation, guiding these activated cells to the draining lymph node to initiate and imprint an adaptive immune response. In this review, we will highlight recent advances in understanding how chemokine function regulates the movement and positioning of innate immune cells at homeostasis and in response to acute inflammation, and then we will review how chemokine-mediated innate immune cell trafficking plays an essential role in linking the innate and adaptive immune responses. hemokines are chemotactic cytokines that with emphasis placed on its role in the innate Ccontrol cell migration and cell positioning immune system. throughout development, homeostasis, and in- flammation. The immune system, which is de- pendent on the coordinated migration of cells, CHEMOKINES AND CHEMOKINE RECEPTORS is particularly dependent on chemokines for its function.
[Show full text]
Characterization of Mononuclear Phagocytic Cells in Medaka Fish
Characterization of mononuclear phagocytic cells in medaka fish transgenic for a cxcr3a:gfp reporter Narges Aghaallaeia,1, Baubak Bajoghlia,1, Heinz Schwarzb, Michael Schorppa, and Thomas Boehma,2 aDepartment of Developmental Immunology, Max-Planck Institute of Immunobiology, D-79108 Freiburg, Germany; and bMax-Planck Institute for Developmental Biology, D-72076 Tübingen, Germany Edited* by Laurie H. Glimcher, Harvard University, Boston, MA, and approved September 10, 2010 (received for review January 13, 2010) Chemokines and chemokine receptors are key evolutionary innova- vertebrates possess many cell types that are characteristic of the tions of vertebrates. They are involved in morphogenetic processes adaptive and innate immune systems of mammals. The sites of or- and play an important role in the immune system. Based on an igin and developmental pathways of lymphocytes (1, 16, 17), as well analysis of the chemokine receptor gene family in teleost genomes, as those of the myeloid lineages (macrophages, neutrophils) (18– and the expression patterns of chemokine receptor genes during 22), have been well characterized. This was achieved by use of cell embryogenesis and the wounding response in young larvae of Ory- type-specific antibodies recognizing characteristic and evolution- zias latipes,weidentified the chemokine receptor cxcr3a as a marker arily conserved cell surface molecules or, for some species—most of innate immune cells. Cells expressing cxcr3a were characterized notably zebrafish—by use of transgenic fish in which the expression in fish transgenic for a cxcr3a:gfp reporter. In embryos and larvae, of fluorescent reporter proteins is directed by the regulatory regions cxcr3a-expressing cells are motile in healthy and damaged tissues, of specific genes to allow the in vivo visualization and preparative and phagocytic; the majority of these cells has the morphology of recovery of individual cell types.
[Show full text]
Role of Chemokines in Hepatocellular Carcinoma (Review)
ONCOLOGY REPORTS 45: 809-823, 2021 Role of chemokines in hepatocellular carcinoma (Review) DONGDONG XUE1*, YA ZHENG2*, JUNYE WEN1, JINGZHAO HAN1, HONGFANG TUO1, YIFAN LIU1 and YANHUI PENG1 1Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050051; 2Medical Center Laboratory, Tongji Hospital Affiliated to Tongji University School of Medicine, Shanghai 200065, P.R. China Received September 5, 2020; Accepted December 4, 2020 DOI: 10.3892/or.2020.7906 Abstract. Hepatocellular carcinoma (HCC) is a prevalent 1. Introduction malignant tumor worldwide, with an unsatisfactory prognosis, although treatments are improving. One of the main challenges Hepatocellular carcinoma (HCC) is the sixth most common for the treatment of HCC is the prevention or management type of cancer worldwide and the third leading cause of of recurrence and metastasis of HCC. It has been found that cancer-associated death (1). Most patients cannot undergo chemokines and their receptors serve a pivotal role in HCC radical surgery due to the presence of intrahepatic or distant progression. In the present review, the literature on the multi- organ metastases, and at present, the primary treatment methods factorial roles of exosomes in HCC from PubMed, Cochrane for HCC include surgery, local ablation therapy and radiation library and Embase were obtained, with a specific focus on intervention (2). These methods allow for effective treatment the functions and mechanisms of chemokines in HCC. To and management of patients with HCC during the early stages, date, >50 chemokines have been found, which can be divided with 5-year survival rates as high as 70% (3). Despite the into four families: CXC, CX3C, CC and XC, according to the continuous development of traditional treatment methods, the different positions of the conserved N-terminal cysteine resi- issue of recurrence and metastasis of HCC, causing adverse dues.
[Show full text]
Exploring the Methylation Status of RAI1 and the RAI1 Consensus Binding Sequence
Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2009 Exploring the Methylation Status of RAI1 and the RAI1 Consensus Binding Sequence Eri Kamura Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medical Genetics Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/1891 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © Eri Kamura 2009 All Rights Reserved Exploring the Methylation Status of RAI1 and the RAI1 Consensus Binding Sequence A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by ERI KAMURA Bachelor of Science (B.S.) Virginia Military Institute, Lexington, Virginia, 2007 Director: Sarah H. Elsea, Ph.D.,F.A.C.M.G. Associate Professor, Departments of Pediatrics and Human and Molecular Genetics Virginia Commonwealth University Richmond, Virginia August, 2009 Acknowledgements First and foremost I would like to thank Dr. Sarah H. Elsea for giving me the opportunity to work and learn in her lab. She provided me with great support and guidance throughout the two years I spent in the lab and was also enjoyable to talk to. I would also like to acknowledge everyone in the Elsea lab starting with Stephen Williams for all his help and guidance. He was always there to address any question and concerns and was pretty much the “go-to-guy” in the lab.
[Show full text]
Expressıon and Functıonal Analysıs of Ccrl2 Atypıcal Chemokıne Receptor
REPUBLIC OF TURKEY HACETTEPE UNIVERSITY INSTITUTE OF HEALTH SCIENCES EXPRESSION AND FUNCTIONAL ANALYSIS OF CCRL2 ATYPICAL CHEMOKINE RECEPTOR VARIANTS ON BREAST CANCER CELLS Dr. Parisa SARMADİ Tumor Biology and Immunology PhD THESIS ANKARA 2014 REPUBLIC OF TURKEY HACETTEPE UNIVERSITY INSTITUTE OF HEALTH SCIENCES EXPRESSION AND FUNCTIONAL ANALYSIS OF CCRL2 ATYPICAL CHEMOKINE RECEPTOR VARIANTS ON BREAST CANCER CELLS Dr. Parisa SARMADİ Tumor Biology and Immunology PhD THESIS Advisor of Thesis Assoc. Prof. Dr. Güneş ESENDAĞLI ANKARA 2014 iii iv ACKNOWLEDGEMENTS I would like to express my deepest gratitude and appreciation to my advisor Assoc. Prof. Dr. Güneş ESENDAĞLI for his support, encouragement, and guidance during all parts of my PhD study. I would like to express my deepest gratitude to Prof. Dr. Emin KANSU for his constitutive support and gentle and kind attitude; also, for his passion in science and transferring it to and inspiring students. I deeply and faithfully thank Prof. Dr. Dicle GÜÇ for her continuous support, kind-heartedness and guidance and for sharing her knowledge and experiences. I would like to gratefully thank Prof. Dr. A. Lale DOĞAN for her support, delicacy and kindness. I would like to cordially express my deepest and infinite gratitude and thankfulness to Asst. Prof. Dr. Hande CANPINAR for her support. I would like to gratefully thank Assoc. Prof. Dr. Güldal YILMAZ from Pathology Department at Gazi University for the great Immunohistochemistry analysis of breast cancer tissues. I would like to thank Asst. Prof. Dr. Füsun ÖZMEN for her kind attitude and support. I would like to gratefully thank Prof. Dr. Petek KORKUSUZ from Histology and Embryology Department and Prof.
[Show full text]
CCRL1 Polyclonal Antibody
PRODUCT DATA SHEET Bioworld Technology,Inc. CCRL1 polyclonal antibody Catalog: BS61526 Host: Rabbit Reactivity: Human,Mouse,Rat BackGround: Applications: Atypical chemokine receptor that controls chemokine WB: 1:500~1:1000 levels and localization via high-affinity chemokine bind- Storage&Stability: ing that is uncoupled from classic ligand-driven signal Store at 4°C short term. Aliquot and store at -20°C long transduction cascades, resulting instead in chemokine se- term. Avoid freeze-thaw cycles. questration, degradation, or transcytosis. Also known as Specificity: interceptor (internalizing receptor) or chemo- CCRL1 polyclonal antibody detects endogenous levels of kine-scavenging receptor or chemokine decoy receptor. CCRL1 protein. Acts as a receptor for chemokines CCL2, CCL8, CCL13, DATA: CCL19, CCL21 and CCL25. Chemokine-binding does not activate G-protein-mediated signal transduction but instead induces beta-arrestin recruitment, leading to lig- and internalization. Plays an important role in controlling the migration of immune and cancer cells that express chemokine receptors CCR7 and CCR9, by reducing the availability of CCL19, CCL21, and CCL25 through in- ternalization. Negatively regulates CXCR3-induced Western blot (WB) analysis of CCRL1 polyclonal antibody at 1:500 di- chemotaxis. Regulates T-cell development in the thymus. lution Product: Lane1:Hela whole cell lysate(40ug) Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, Lane2:HEK293T whole cell lysate(40ug) 50% glycerol, pH7.2 Lane3:L02 whole cell lysate(40ug) Molecular Weight: Lane4:The heart tissue lysate of Mouse(40ug) ~ 40 kDa Lane5:The heart tissue lysate of Rat(40ug) Swiss-Prot: Note: Q9NPB9 For research use only, not for use in diagnostic procedure.
[Show full text]
Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma ASHLEY C
ANTICANCER RESEARCH 36 : 4013-4018 (2016) Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma ASHLEY C. MAYS, XIN FENG, JAMES D. BROWNE and CHRISTOPHER A. SULLIVAN Department of Otolaryngology, Wake Forest School of Medicine, Winston Salem, NC, U.S.A. Abstract. Aim: To characterize the chemokine pattern in distant metastasis (2-5). According to Ko et al. , 75% of metastatic salivary adenoid cystic carcinoma (SACC). patients with initial nodal involvement eventually developed Materials and Methods: Real-time polymerase chain distant metastasis. Patients with lung metastasis have a poor reaction (RT-PCR) was used to compare chemokine and prognosis (6). chemokine receptor gene expression in two SACC cell lines: The development of distant metastatic disease is the chief SACC-83 and SACC-LM (lung metastasis). Chemokines and cause for mortality (7, 8). Primary treatment is complete receptor genes were then screened and their expression surgical resection when feasible with adjuvant radiotherapy. pattern characterized in human tissue samples of non- The role of chemotherapy is debatable. Treatment of recurrent SACC and recurrent SACC with perineural metastatic ACC has been difficult to date due to lack of invasion. Results: Expression of chemokine receptors specific targets for metastatic cells (1). Though the steps that C5AR1, CCR1, CCR3, CCR6, CCR7, CCR9, CCR10, must occur in the metastatic event are well characterized, it CXCR4, CXCR6, CXCR7, CCRL1 and CCRL2 were higher remains unclear why or how ACC cells ultimately “choose” in SACC-83 compared to SACC-LM. CCRL1, CCBP2, or are ”chosen” to migrate to a specific metastatic site. A CMKLR1, XCR1 and CXCR2 and 6 chemokine genes mounting body of evidence suggests that cytokine-like (CCL13, CCL27, CXCL14, CMTM1, CMTM2, CKLF) were molecules called chemokines play a significant role in more highly expressed in tissues of patients without tumor directing the cellular traffic in metastatic melanoma, lung, recurrence/perineural invasion compared to those with breast and ACC cancers (9-15).
[Show full text]
Mechanisms of Regulation of the Chemokine-Receptor Network
International Journal of Molecular Sciences Review Mechanisms of Regulation of the Chemokine-Receptor Network Martin J. Stone 1,2,*, Jenni A. Hayward 1,2, Cheng Huang 1,2, Zil E. Huma 1,2 and Julie Sanchez 1,2 1 Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; [email protected] (J.A.H.); [email protected] (C.H.); [email protected] (Z.E.H.); [email protected] (J.S.) 2 Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia * Correspondence: [email protected]; Tel.: +61-3-9902-9246 Academic Editor: Elisabetta Tanzi Received: 21 December 2016; Accepted: 26 January 2017; Published: 7 February 2017 Abstract: The interactions of chemokines with their G protein-coupled receptors promote the migration of leukocytes during normal immune function and as a key aspect of the inflammatory response to tissue injury or infection. This review summarizes the major cellular and biochemical mechanisms by which the interactions of chemokines with chemokine receptors are regulated, including: selective and competitive binding interactions; genetic polymorphisms; mRNA splice variation; variation of expression, degradation and localization; down-regulation by atypical (decoy) receptors; interactions with cell-surface glycosaminoglycans; post-translational modifications; oligomerization; alternative signaling responses; and binding to natural or pharmacological inhibitors. Keywords: chemokine; chemokine receptor; regulation; binding; expression; glycosaminoglycan; post-translational modification; oligomerization; signaling; inhibitor 1. Introduction It has long been recognized that a hallmark feature of the inflammatory response is the accumulation of leukocytes (white blood cells) in injured or infected tissues, where they remove pathogens and necrotic tissue by phagocytosis and proteolytic degradation.
[Show full text]
Glucocorticoids Suppress CCR9-Mediated Chemotaxis, Calcium Flux, and Adhesion to Madcam-1 in Human T Cells
Glucocorticoids Suppress CCR9-Mediated Chemotaxis, Calcium Flux, and Adhesion to MAdCAM-1 in Human T Cells This information is current as Emily Wendt, Gemma E. White, Helen Ferry, Michael of September 25, 2021. Huhn, David R. Greaves and Satish Keshav J Immunol published online 25 March 2016 http://www.jimmunol.org/content/early/2016/03/24/jimmun ol.1500619 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2016/03/24/jimmunol.150061 Material 9.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published March 25, 2016, doi:10.4049/jimmunol.1500619 The Journal of Immunology Glucocorticoids Suppress CCR9-Mediated Chemotaxis, Calcium Flux, and Adhesion to MAdCAM-1 in Human T Cells Emily Wendt,* Gemma E. White,† Helen Ferry,‡ Michael Huhn,* David R. Greaves,† and Satish Keshav* CCR9 expressed on T lymphocytes mediates migration to the small intestine in response to a gradient of CCL25.
[Show full text]